Modern strategy for preclinical pharmaceutical R&D: towards the virtual research company
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Chichester ; New York ; Weinheim ; Brisbane ; Singapore ; Toronto
John Wiley & Sons
[1997]
|
| Schlagworte: | |
| Beschreibung: | x, 218 Seiten Illustrationen, Diagramme |
| ISBN: | 0471971170 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV044467593 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 170830s1997 a||| |||| 00||| eng d | ||
| 020 | |a 0471971170 |9 0-471-97117-0 | ||
| 035 | |a (OCoLC)1004318201 | ||
| 035 | |a (DE-599)HBZHT007713459 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 100 | 1 | |a Cavalla, David |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Modern strategy for preclinical pharmaceutical R&D |b towards the virtual research company |c David Cavalla with contributions from John Flack and Richard Jennings |
| 264 | 1 | |a Chichester ; New York ; Weinheim ; Brisbane ; Singapore ; Toronto |b John Wiley & Sons |c [1997] | |
| 300 | |a x, 218 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 2 | |a Drug Industry |a organization & administration | |
| 650 | 2 | |a Drug Industry |a economics | |
| 650 | 2 | |a Research Design | |
| 700 | 1 | |a Flack, John |e Verfasser |4 aut | |
| 700 | 1 | |a Jennings, Richard |d 1948- |e Verfasser |0 (DE-588)135751276 |4 aut | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029868095 | ||
Datensatz im Suchindex
| _version_ | 1804177795803250688 |
|---|---|
| any_adam_object | |
| author | Cavalla, David Flack, John Jennings, Richard 1948- |
| author_GND | (DE-588)135751276 |
| author_facet | Cavalla, David Flack, John Jennings, Richard 1948- |
| author_role | aut aut aut |
| author_sort | Cavalla, David |
| author_variant | d c dc j f jf r j rj |
| building | Verbundindex |
| bvnumber | BV044467593 |
| ctrlnum | (OCoLC)1004318201 (DE-599)HBZHT007713459 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01142nam a2200313 c 4500</leader><controlfield tag="001">BV044467593</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">170830s1997 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471971170</subfield><subfield code="9">0-471-97117-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1004318201</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZHT007713459</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cavalla, David</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Modern strategy for preclinical pharmaceutical R&D</subfield><subfield code="b">towards the virtual research company</subfield><subfield code="c">David Cavalla with contributions from John Flack and Richard Jennings</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chichester ; New York ; Weinheim ; Brisbane ; Singapore ; Toronto</subfield><subfield code="b">John Wiley & Sons</subfield><subfield code="c">[1997]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 218 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Industry</subfield><subfield code="a">organization & administration</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Industry</subfield><subfield code="a">economics</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Research Design</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flack, John</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jennings, Richard</subfield><subfield code="d">1948-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)135751276</subfield><subfield code="4">aut</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029868095</subfield></datafield></record></collection> |
| id | DE-604.BV044467593 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:53:46Z |
| institution | BVB |
| isbn | 0471971170 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029868095 |
| oclc_num | 1004318201 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | x, 218 Seiten Illustrationen, Diagramme |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | John Wiley & Sons |
| record_format | marc |
| spelling | Cavalla, David Verfasser aut Modern strategy for preclinical pharmaceutical R&D towards the virtual research company David Cavalla with contributions from John Flack and Richard Jennings Chichester ; New York ; Weinheim ; Brisbane ; Singapore ; Toronto John Wiley & Sons [1997] x, 218 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Drug Industry organization & administration Drug Industry economics Research Design Flack, John Verfasser aut Jennings, Richard 1948- Verfasser (DE-588)135751276 aut |
| spellingShingle | Cavalla, David Flack, John Jennings, Richard 1948- Modern strategy for preclinical pharmaceutical R&D towards the virtual research company Drug Industry organization & administration Drug Industry economics Research Design |
| title | Modern strategy for preclinical pharmaceutical R&D towards the virtual research company |
| title_auth | Modern strategy for preclinical pharmaceutical R&D towards the virtual research company |
| title_exact_search | Modern strategy for preclinical pharmaceutical R&D towards the virtual research company |
| title_full | Modern strategy for preclinical pharmaceutical R&D towards the virtual research company David Cavalla with contributions from John Flack and Richard Jennings |
| title_fullStr | Modern strategy for preclinical pharmaceutical R&D towards the virtual research company David Cavalla with contributions from John Flack and Richard Jennings |
| title_full_unstemmed | Modern strategy for preclinical pharmaceutical R&D towards the virtual research company David Cavalla with contributions from John Flack and Richard Jennings |
| title_short | Modern strategy for preclinical pharmaceutical R&D |
| title_sort | modern strategy for preclinical pharmaceutical r d towards the virtual research company |
| title_sub | towards the virtual research company |
| topic | Drug Industry organization & administration Drug Industry economics Research Design |
| topic_facet | Drug Industry organization & administration Drug Industry economics Research Design |
| work_keys_str_mv | AT cavalladavid modernstrategyforpreclinicalpharmaceuticalrdtowardsthevirtualresearchcompany AT flackjohn modernstrategyforpreclinicalpharmaceuticalrdtowardsthevirtualresearchcompany AT jenningsrichard modernstrategyforpreclinicalpharmaceuticalrdtowardsthevirtualresearchcompany |